Syntheses and structure-activity relationships of novel, potent, and selective trans-2-[3-oxospiro[isobenzofuran-1(3H),1′-cyclohexan]-4′-yl]benzimidazole NPYY5 receptor antagonists

被引：19

作者：

Ogino, Yoshio ^{[1
]}

Ohtake, Norikazu ^{[1
]}

Nagae, Yoshikazu ^{[1
]}

Matsuda, Kenji ^{[1
]}

Ishikawa, Makoto ^{[1
]}

Moriya, Minoru ^{[1
]}

Kanesaka, Maki ^{[1
]}

Mitobe, Yuko ^{[1
]}

Ito, Junko ^{[1
]}

Kanno, Tetsuya ^{[1
]}

Ishihara, Akane ^{[1
]}

Iwaasa, Hisashi ^{[1
]}

Ohe, Tomoyuki ^{[1
]}

Kanatani, Akio ^{[1
]}

Fukami, Takehiro ^{[1
]}

机构：

[1] Banyu Pharmaceut Co Ltd, Banyu Tsukuba Res Inst, Tsukuba, Ibaraki 3002611, Japan

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2008年 / 18卷 / 18期

关键词：

neuropeptide Y; Y5; receptor; antagonist; anti-obesity; benzimidazole;

D O I：

10.1016/j.bmcl.2008.08.021

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Syntheses and structure-activity relationships of a novel class of 2-[3-oxospiro[isobenzofuran-1(3H), 1'-cyclohexan]-4'-yl]benzimidazole NPY Y5 receptor antagonists are described. Optimization of the lead compound 2a by incorporating substituents into the 5-position or into both the 5-and 6-positions of the benzimidazole core part led to the identification of 5-(5-methyl-1,2,4-oxadiazol-2-yl) benzimidazole (2r: IC(50) = 3.3 nM) and 5-(2-methyltetrazol-5-yl) benzimidazole (2u: IC(50) = 5.9 nM), both of which are potent, selective, and orally bioavailable Y5 receptor antagonists. Crown Copyright (C) 2008 Published by Elsevier Ltd. All rights reserved.

引用

页码：4997 / 5001

页数：5

共 50 条

[31] Novel 1,3-Dipropyl-8-(3-benzimidazol-2-yl-methoxy-1-methylpyrazol-5-yl)xanthines as Potent and Selective A2B Adenosine Receptor Antagonists
Baraldi, Pier Giovanni
Baraldi, Stefania
Saponaro, Giulia
Preti, Delia
Romagnoli, Romeo
Piccagli, Laura
Cavalli, Andrea
Recanatini, Maurizio
Moorman, Allan R.
Zaid, Abdel Naser
Varani, Katia
Borea, Pier Andrea
Tabrizi, Mojgan Aghazadeh
JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (02) : 797 - 811
[32] Synthesis and structure-activity relationships of 1-(1(3)H-imidazole-5(4)-yl)-methylpyrroles as farnesyl protein transferase inhibitors (FTPI).
Lee, H
Lee, J
Shin, Y
Jung, WH
Kim, JH
Park, K
Kim, M
Moon, K
Kim, HS
Lee, SH
Lee, S
Ro, S
Chung, HH
Koh, O
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1999, 218 : U983 - U983
[33] SYNTHESES WITH ALKENEDIAZONIUM SALTS .6. 2,2-DIETHOXY-1-ETHENEDIAZONIUM HEXACHLOROANTIMONATE - A VERSATILE BUILDING BLOCK FOR THE SYNTHESIS OF 5-MEMBERED AND 6-MEMBERED N-HETEROCYCLES CRYSTAL AND MOLECULAR-STRUCTURE OF 5'-PHENYL-3'-(2-PHENYL-6H-1,3,4-OXADIAZINE-5-YL)SPIRO[ISOBENZOFURAN-1(3H),2'(3'H)-[1,3,4]-OXADIAZOL]-3-ONE[1]
SAALFRANK, RW
WEISS, B
WIRTH, U
PETERS, K
VONSCHNERING, HG
ZEITSCHRIFT FUR NATURFORSCHUNG SECTION B-A JOURNAL OF CHEMICAL SCIENCES, 1989, 44 (05): : 587 - 597
[34] The discovery and structure-activity relationships of 2-(piperidin-3-yl)-1H-benzimidazoles as selective, CNS penetrating H1-antihistamines for insomnia
Lavrador-Erb, Karine
Ravula, Satheesh Babu
Yu, Jinghua
Zamani-Kord, Said
Moree, Wilna J.
Petroski, Robert E.
Wen, Jianyun
Malany, Siobhan
Hoare, Samuel R. J.
Madan, Ajay
Crowe, Paul D.
Beaton, Graham
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (09) : 2916 - 2919
[35] Discovery of trans-N-[1-(2-fluorophenyl)-3-pyrazolyl]-3-oxospiro-[6-azaisobenzofuran-1(3H),1′-cyclohexane]-4′-carboxamide, a potent and orally active neuropeptide Y Y5 receptor antagonist
Haga, Yuji
Sakamoto, Toshihiro
Shibata, Takunobu
Nonoshita, Katsumasa
Ishikawa, Makoto
Suga, Takuya
Takahashi, Hirobumi
Takahashi, Toshiyuki
Takahashi, Hidekazu
Ando, Makoto
Murai, Takashi
Gomori, Akira
Oda, Zenjun
Kitazawa, Hidefumi
Mitobe, Yuko
Kanesaka, Maki
Ohe, Tomoyuki
Iwaasa, Hisashi
Ishii, Yasuyuki
Ishihara, Akane
Kanatani, Akio
Fukami, Takehiro
BIOORGANIC & MEDICINAL CHEMISTRY, 2009, 17 (19) : 6971 - 6982
[36] Novel alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate receptor antagonists: Synthesis and structure-activity relationships of 6-(1H-imidazol-1-yl)-7-nitro-2,3(1H,4H)-pyrido[2,3-b]pyrazinedione and related compounds
Ohmori, J
Kubota, H
ShimizuSasamata, M
Okada, M
Sakamoto, S
JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (06) : 1331 - 1338
[37] N,N-Dimethyl-[9-(arylsulfonyl)-2,3,4,9-tetrahydro-1H-carbazol-3-yl]amines as novel, potent and selective 5-HT6 receptor antagonists
Nirogi, Ramakrishna V. S.
Konda, Jagadishu Babu
Kambhampati, Ramasastry
Shinde, Anil
Bandyala, Thrinath Reddy
Gudla, Parandhama
Kandukuri, Kiran Kumar
Jayarajan, Pradeep
Kandikere, Vishwottam
Dubey, P. K.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (22) : 6980 - 6985
[38] Structure-Activity Relationship and Neuroprotective Activity of 1,5-Dihydro-2H-naphtho[1,2-b][1,4]diazepine-2,4(3H)-diones as P2X4 Receptor Antagonists
Toti, Kiran S.
Verma, Rajkumar
McGonnigle, Michael J.
Turro, Daylin Gamiotea
Wen, Zhiwei
Lewicki, Sarah A.
Liang, Bruce T.
Jacobson, Kenneth A.
JOURNAL OF MEDICINAL CHEMISTRY, 2022, 65 (20) : 13967 - 13987
[39] Design, synthesis, and structure-activity relationships of novel 2-arylimidazolo[1,2-a]pyrimid-4-ones as potent GnRH receptor antagonists.
Gross, T
Zhu, YF
Wilcoxen, K
Struthers, S
Saunders, J
Gao, YH
Connors, P
Guo, ZQ
Reinhart, G
Ling, N
Chen, C
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 221 : U38 - U38
[40] DEVELOPMENT OF POTENT SEROTONIN-3 (5-HT3) RECEPTOR ANTAGONISTS .1. STRUCTURE-ACTIVITY-RELATIONSHIPS OF 2-ALKOXY-4-AMINO-5-CHLOROBENZAMIDE DERIVATIVES
HARADA, H
MORIE, T
HIROKAWA, Y
YOSHIDA, N
KATO, S
CHEMICAL & PHARMACEUTICAL BULLETIN, 1995, 43 (08) : 1364 - 1378

← 1 2 3 4 5 →